Related references
Note: Only part of the references are listed.Ceramide-palmitic acid complex based Curcumin solid lipid nanoparticles for transdermal delivery: pharmacokinetic and pharmacodynamic study
Praveen Kumar Gaur et al.
JOURNAL OF EXPERIMENTAL NANOSCIENCE (2016)
Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the, lipopolysaccharide-induced sepsis
Jiao Wang et al.
BIOMATERIALS (2015)
Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells
Piera Sozio et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: Preparation and characterization
Sara Laserra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway
Jiao Wang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease
Rahul Bhatt et al.
DRUG DELIVERY (2015)
Synthesis of a Novel Cyclic Prodrug of S-Allyl-glutathione Able To Attenuate LPS-Induced ROS Production through the Inhibition of MAPK Pathways in U937 Cells
Antonia Patruno et al.
MOLECULAR PHARMACEUTICS (2015)
Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art
Lucia Gastaldi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
Hao Dang et al.
JOURNAL OF NANOPARTICLE RESEARCH (2014)
Curcumin Nanoparticles Attenuate Neurochemical and Neurobehavioral Deficits in Experimental Model of Huntington's Disease
Rajat Sandhir et al.
NEUROMOLECULAR MEDICINE (2014)
Alzheimer, dementia and the living will: a proposal
Claudia Burla et al.
MEDICINE HEALTH CARE AND PHILOSOPHY (2014)
A Glutathione Derivative with Chelating and in vitro Neuroprotective Activities: Synthesis, Physicochemical Properties, and Biological Evaluation
Ivana Cacciatore et al.
CHEMMEDCHEM (2013)
Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach
Chandrakantsing V. Pardeshi et al.
DRUG DELIVERY (2013)
Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease
Piera Sozio et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles
Medha Patel et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model
Mohammad Yusuf et al.
JOURNAL OF DRUG TARGETING (2013)
Raman spectroscopy in nanomedicine: current status and future perspective
Mark E. Keating et al.
NANOMEDICINE (2013)
Current and future treatments for Alzheimer's disease
Konstantina G. Yiannopoulou et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model
Alba Minelli et al.
AMINO ACIDS (2012)
(R)-α-Lipoyl-Glycyl-L-Prolyl-L-Glutamyl Dimethyl Ester Codrug as a Multifunctional Agent with Potential Neuroprotective Activities
Ivana Cacciatore et al.
CHEMMEDCHEM (2012)
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Lucia Montenegro et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2011)
Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain
Vandita Kakkar et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations
Ming-Jun Tsai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
Sanju Dhawan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Disease-modifying treatments for Alzheimer’s disease
Daniela Galimberti et al.
Therapeutic Advances in Neurological Disorders (2011)
Ibuprofen and Lipoic Acid Diamides as Potential Codrugs with Neuroprotective Activity
Piera Sozio et al.
ARCHIV DER PHARMAZIE (2010)
Lipid-based nanoparticles with high binding affinity for amyloid-β1-42 peptide
Marco Gobbi et al.
BIOMATERIALS (2010)
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity
Alba Minelli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease
Adam Smith et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution
Maria Luisa Bondi et al.
NANOMEDICINE (2010)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
Parag Aggarwal et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles
Pasquale Picone et al.
FREE RADICAL RESEARCH (2009)
Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System
S. Mukherjee et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Optimizing phase II of drug development for disease-modifying compounds
Jeffrey L. Cummings
ALZHEIMERS & DEMENTIA (2008)
New L-dopa codrugs as potential antiparkinson agents
Piera Sozio et al.
ARCHIV DER PHARMAZIE (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Solid lipid nanoparticles as delivery systems for bromocriptine
Elisabetta Esposito et al.
PHARMACEUTICAL RESEARCH (2008)
Modelling of the blood-brain barrier in drug discovery and development
Romeo Cecchelli et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Medical management of levodopa-associated motor complications in patients with Parkinson's disease
Joseph Jankovic et al.
CNS DRUGS (2007)
Nanomedicine: Developing smarter therapeutic and diagnostic modalities
Omid C. Farokhzad et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
A novel approach based on lipid nanoparticles (SLN®) for topical delivery of α-lipoic acid
EB Souto et al.
JOURNAL OF MICROENCAPSULATION (2005)
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice
MO Oyewumi et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Cholinergic enhancement of frontal lobe activity in mild cognitive impairment
AJ Saykin et al.
BRAIN (2004)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
Solid lipid nanoparticles for parenteral drug delivery
SA Wissing et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
In silico prediction of blood-brain barrier permeation
DE Clark
DRUG DISCOVERY TODAY (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
RH Müller et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Solid lipid nanoparticles -: Production, characterization and applications
W Mehnert et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-dopa
GM Cingolani et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
